Autor según el artículo: Santos, JL; Ruiz-Canela, M; Razquin, C; Clish, CB; Guasch-Ferré, M; Babio, N; Corella, D; Gómez-Gracia, E; Fiol, M; Estruch, R; Lapetra, J; Fitó, M; Aros, F; Serra-Majem, L; Liang, LM; Martínez, MA; Toledo, E; Salas-Salvadó, J; Hu, FB; Martínez-González, MA
Departamento: Bioquímica i Biotecnologia
Autor/es de la URV: Babio Sánchez, Nancy Elvira / Martínez Rodríguez, María Ángeles / Salas Salvadó, Jorge
Palabras clave: Tricarboxylic cycle Stroke Risk factors Middle aged Metabolomics Mediterranean diet Male Malates Humans Female Diet, mediterranean Cohort studies Citric acid cycle Case-control studies Cardiovascular diseases Cardiovascular disease Aged, 80 and over Aged tricarboxylic cycle trial stroke profiles plasma lactate metabolomics heart cardiovascular disease
Resumen: Background and aim: Plasma citric acid cycle (CAC) metabolites might be likely related to cardiovascular disease (CVD). However, studies assessing the longitudinal associations between circulating CAC-related metabolites and CVD risk are lacking. The aim of this study was to evaluate the association of baseline and 1-year levels of plasma CAC-related metabolites with CVD incidence (a composite of myocardial infarction, stroke or cardiovascular death), and their interaction with Mediterranean diet interventions. Methods and results: Case-cohort study from the PREDIMED trial involving participants aged 55–80 years at high cardiovascular risk, allocated to MedDiets or control diet. A subcohort of 791 participants was selected at baseline, and a total of 231 cases were identified after a median follow-up of 4.8 years. Nine plasma CAC-related metabolites (pyruvate, lactate, citrate, aconitate, isocitrate, 2-hydroxyglutarate, fumarate, malate and succinate) were measured using liquid chromatography-tandem mass spectrometry. Weighted Cox multiple regression was used to calculate hazard ratios (HRs). Baseline fasting plasma levels of 3 metabolites were associated with higher CVD risk, with HRs (for each standard deviation, 1-SD) of 1.46 (95%CI:1.20–1.78) for 2-hydroxyglutarate, 1.33 (95%CI:1.12–1.58) for fumarate and 1.47 (95%CI:1.21–1.78) for malate (p of linear trend <0.001 for all). A higher risk of CVD was also found for a 1-SD increment of a combined score of these 3 metabolites (HR = 1.60; 95%CI: 1.32–1.94, p trend <0.001). This result was replicated using plasma measurements after one-year. No interactions were detected with the nutritional intervention. Conclusion: Plasma 2-hydroxyglutarate, fumarate and malate levels were prospectively associated with increased cardiovascular risk. Clinical trial number: ISRCTN35739639
Áreas temáticas: Serviço social Saúde coletiva Nutrition and dietetics Nutrition & dietetics Nutrição Medicine (miscellaneous) Medicina veterinaria Medicina iii Medicina ii Medicina i Interdisciplinar General medicine Farmacia Enfermagem Endocrinology, diabetes and metabolism Endocrinology & metabolism Educação física Ciências biológicas ii Ciências biológicas i Ciências ambientais Cardiology and cardiovascular medicine Cardiac & cardiovascular systems
Acceso a la licencia de uso: https://creativecommons.org/licenses/by/3.0/es/
Direcció de correo del autor: mangeles.martinez@urv.cat jordi.salas@urv.cat nancy.babio@urv.cat
Identificador del autor: 0000-0001-8595-3772 0000-0003-2700-7459 0000-0003-3527-5277
Fecha de alta del registro: 2024-08-03
Versión del articulo depositado: info:eu-repo/semantics/publishedVersion
Enlace a la fuente original: https://www.nmcd-journal.com/article/S0939-4753(23)00007-8/fulltext
URL Documento de licencia: https://repositori.urv.cat/ca/proteccio-de-dades/
Referencia al articulo segun fuente origial: Nutrition Metabolism And Cardiovascular Diseases. 33 (4): 835-843
Referencia de l'ítem segons les normes APA: Santos, JL; Ruiz-Canela, M; Razquin, C; Clish, CB; Guasch-Ferré, M; Babio, N; Corella, D; Gómez-Gracia, E; Fiol, M; Estruch, R; Lapetra, J; Fitó, M; A (2023). Circulating citric acid cycle metabolites and risk of cardiovascular disease in the PREDIMED study. Nutrition Metabolism And Cardiovascular Diseases, 33(4), 835-843. DOI: 10.1016/j.numecd.2023.01.002
DOI del artículo: 10.1016/j.numecd.2023.01.002
Entidad: Universitat Rovira i Virgili
Año de publicación de la revista: 2023
Tipo de publicación: Journal Publications
Repositori URV